India's Solara Active Sciences jumps on European nod for Vizag unit

Solara Active Pharma Sciences

01/11/2022 07:51

** Shares of Indian active pharmaceutical ingredients maker Solara Active
Pharma Sciences Ltd  SOLA.NS  rise as much as 5.2% to 419.00 rupees, highest pct
gain since Oct. 3
    ** SOLA on Tuesday received European approval to manufacture Ibuprofen
from its flagship facility in Visakhapatnam
   ** Co also expects series of other international regulatory approvals for the
facility, including USFDA 
    ** More than 196,000 shares change hands by 0734 GMT, 2.4X 30-day avg of
81,486 shares
    ** SOLA set to gain after four straight sessions of losses
    ** Stock down 60.9% so far this year, as of last close
 (Reporting by Anisha Ajith in Bengaluru)
 ((anisha.ajith@thomsonreuters.com;))